Market Tracker

01/27 5:14am ET

Novo Nordisk A/S (NYSE:NVO)

137.44
Delayed Data
As of Jan 26
 -0.10 / -0.07%
Today’s Change
92.69
Today|||52-Week Range
144.78
+1.55%
Year-to-Date

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 147.78, with a high estimate of 174.72 and a low estimate of 75.50. The median estimate represents a +7.52% increase from the last price of 137.44.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.84
Sales
$6.8B
Reporting Date
Feb 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -0.69%
 
 
 
 
 
 
Growthannually 10.46%
 
 
 
 
 
 

Sales

Growthquarterly 12.38%
 
 
 
 
 
 
Growthannually 17.84%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.